0001104659-24-042348.txt : 20240402 0001104659-24-042348.hdr.sgml : 20240402 20240402120222 ACCESSION NUMBER: 0001104659-24-042348 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240326 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashman Philip CENTRAL INDEX KEY: 0001564990 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34703 FILM NUMBER: 24812877 MAIL ADDRESS: STREET 1: 6120 WINDWARD PARKWAY, SUITE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALIMERA SCIENCES INC CENTRAL INDEX KEY: 0001267602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 200028718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-990-5740 MAIL ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 tm2410164-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-26 0 0001267602 ALIMERA SCIENCES INC ALIM 0001564990 Ashman Philip 6310 TOWN SQUARE, SUITE 400 ALPHARETTA GA 30005 0 1 0 0 President of Int'l Operations 0 Common Stock 2024-03-26 4 F 0 12103 3.83 D 118274 D Represents shares of the Issuer's restricted common stock sold to satisfy tax obligations relating to the vesting of shares of the Issuer's restricted common stock previously awarded to the Reporting Person. Such sale was executed pursuant to the mandatory terms of the Issuer's restricted stock award agreement that are intended to permit such sale to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to comply with the requirements of Rule 10b5-1(c). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.88 to $3.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Philip Ashman 2024-04-02